Company page

Stereotaxis, Inc.

Stereotaxis, Inc. is a public company traded under the ticker STXS in the American market, with a market capitalization of approximately $126.3 million. The company specializes in advanced robotic technologies for cardiac procedures. Stereotaxis aims to improve patient outcomes and enhance the efficiency of cardiac care through its innovative solutions.